BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2007
View Archived Issues
Recent patents impart new therapeutic agents for cancer
Read More
Recent patents disclose new agents for metabolic disorders
Read More
Novel treatment option for respiratory disorders claimed in recent Argenta patent
Read More
MEND-CABG II study of MC-1 recommended to continue
Read More
CollaGenex discontinues 40 mg cohort in phase II acne study of incyclinide
Read More
COSTAR II study fails to meet endpoints
Read More
New data indicate Homspera may demonstrate adjuvant capabilities
Read More
TorreyPines to sell assets for treating autoimmune diseases to CalciMedica
Read More
New bioavailability data for BEMA Fentanyl
Read More
Australian TGA accepts Solbec's development plan for Coramsine
Read More
Interim three-month data for ISA-247 kidney transplant trial
Read More
Preliminary phase IIa data indicate utility of AT-1001 in celiac disease
Read More
New data on NX-1207 show sustained symptomatic improvement in BPH
Read More
AEterna Zentaris updates clinical progress
Read More
European CHMP recommends approval of Siklos
Read More
TRPV1 channel as a novel drug target in ocular disorders
Read More
Recent clinical data on intravitreal bevacizumab in ophthalmological conditions
Read More
Calcineurin inhibitor-free regimen with CP-690550 effective in renal transplantation
Read More
Studies show efficacy of lamotrigine in epilepsy
Read More
Abatacept associated with reduced flare incidence in juvenile idiopathic arthritis
Read More
Vision maintained with combretastatin A-4 in choroidal neovascularization patients
Read More
SRI International regains rights to tirapazamine from sanofi-aventis
Read More
Omrix seeks Swedish approval for HBIG product
Read More
New licensing agreement for NM-702 for arteriosclerosis obliterans
Read More
AEterna Zentaris regains rights for cetrorelix from Solvay
Read More
Fabre-Kramer amends NDA for gepirone ER in major depressive disorder
Read More
Adverse event reported in phase II anemia trial of FG-2216
Read More
PAC-113 active in the treatment of oral Candida infection
Read More